Investor's Business Daily on MSN9m
AstraZeneca Dips On Surprise Miss For Gilead-Rivaling Cancer DrugAstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast ...
Key Takeaways A breast cancer drug being developed by AstraZeneca failed to "achieve statistical significance" in helping ...
For trade group the Pharmaceutical Research and Manufacturers of America (PhRMA), the fight against pricing provisions in the ...
The approved indication involves using durvalumab in combination with chemotherapy as a neoadjuvant treatment, followed by ...
Forbes recently listed the best employers in the U.S. and in each state for 2024, with 15 Delaware employers included. Find out how they fared.
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids AstraZeneca’s Fasenra (benralizumab) ...
"Vicebio secures $100m to advance RSV and hMPV vaccine combo to Phase I" was originally created and published by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback